Navigation Links
New Jersey Health Foundation Awards $50,000 Grant For Research to Facilitate Stem Cell Growth
Date:10/21/2013

NEW BRUNSWICK, N.J., Oct. 21, 2013 /PRNewswire-USNewswire/ -- Dr. Steven Levison has received a $50,000 Innovation Stage Funding Grant from New Jersey Health Foundation to advance research that could make stem cell growth easier and less expensive for researchers, scientists and others interested in using stem cells to advance medical studies.

Dr. Levison, a professor in the Department of Neurology and Neurosciences at Rutgers New Jersey Medical School (NJMS), has worked collaboratively with colleagues at NJMS and at the New Jersey Institute of Technology to develop a multifunctional matrix that allows neural stem cells to be propagated as undifferentiated cells without daily feeding.

"Our cell culture matrices and supplements can be used in regenerative medicine, biotechnology and life science research," explained Dr. Levison. "We can manufacture products that don't contain animal components so that they are suitable for clinical applications."

Dr. Levison explained that he and his research team have formulated and rigorously tested a novel growth matrix that promotes the proliferation and multipotency of neural stem cells. Commercially available matrices today, he said, do not incorporate defined growth factors.  While some matrices do contain growth factors, they are not defined or suitable for therapeutic use.

"We are very interested in helping Dr. Levison advance his research because we believe this product could be commercialized successfully to be of tremendous benefit to the research community," explained Dr. George F. Heinrich, vice chair and CEO of New Jersey Health Foundation.  "His unique product reduces the time-consuming and tedious task of feeding stem cells on a daily basis, which will save researchers time and money."

Dr. Levison and his research team are presently modifying the scaffold to incorporate a variety of growth factors known to be beneficial for propagating other types of stem cells and progenitors. 

Through the Innovation Stage Funding program, New Jersey health Foundation (www.njhf.org) has allocated $500,000 to provide grants from $10,000 to $50,000 each to researchers at the Rutgers School of Biomedical and Health Sciences who have promising ideas to advance an intellectual property toward commercialization through a start-up. 

About New Jersey Health Foundation
New Jersey Health Foundation (www.njhf.org) is a not-for-profit corporation that supports biomedical research and health-related education programs in New Jersey through its matching program, its Grants Program and its affiliate, Foundation Venture Capital Group (www.foundationventure.com) which makes private equity investments in life science start- up companies in New Jersey headed toward commercialization.


'/>"/>
SOURCE New Jersey Health Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunrise Pharmaceutical, Inc. Sued for Violation of New Jersey Consumer Fraud Act
2. Cardiac Science signs contract to provide Powerheart AEDs to the state of New Jersey
3. Big Pharma to Come Together at ChemOutsourcing 2013 in Long Branch, New Jersey, Sept 16-19
4. ChemOutsourcing Announces 100 CMO and CRO Exhibitors for September 2013 Show in Long Branch, New Jersey
5. ChemOutsourcing Announces 30 Pharma Company Presenters for September 2013 Outsourcing Show in New Jersey
6. NJBIZ Honors New Jerseys General Counsels
7. Growth Fuels Expansion As PendoTECH Relocates New Jersey Headquarters
8. South Jersey Healthcare Selects Perioperative Management By Surgical Information Systems
9. New Jersey Health Foundation Awards First Two Innovation Stage Funding Grants
10. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
11. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that its ... Inc., has recently opened a New York City Office in ... of its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. ... Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS accreditation ... ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... Mich. , Aug. 7, 2017 Diplomat Pharmacy, ... of Joel Saban as president, effective Aug. 7, ... Urick has decided to pursue other interests and will ... "During his tenure, Paul has served us in multiple leadership ... Specialty Pharmacy in Jun. 2015 and has provided decisive, strategic ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... ... Maury Regional Health has announced a large-scale adoption of AccuVein vein visualization ... Regional Medical Center is making vein visualization part of their standard of care. , ... importantly, helps our staff members locate a vein that will provide good access to ...
(Date:8/16/2017)... ... August 16, 2017 , ... A global leader in the treatment ... clinics in all 29 Indian states—bringing the country one step closer to eliminating clubfoot ... the nonprofit organization is on track to enroll 10,000 children in the clubfoot treatment ...
(Date:8/16/2017)... ... , ... Fusion Flix Inc., a Telly Award Winning, Non Profit Corporation has ... viewers in a partnership with the Amazon Video Direct Streaming Distribution Platform. , Their ... Ray disc in 2018. Proceeds will be going to further health research. , ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... TopConsumerReviews.com recently ... Lab Testing . , The healthcare industry in the United States has undergone ... are the days of needing to have a doctor’s order to get a blood ...
(Date:8/16/2017)... , ... August 16, 2017 , ... First Choice ... States, named Dr. Douglas J. Harrison, as the new Medical Director of its Sienna ... new facility Medical Director of our Sienna Plantation location,” said Dr. Michael (Derek) Caraway, ...
Breaking Medicine News(10 mins):